BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leamon CP, Reddy JA, Dorton R, Bloomfield A, Emsweller K, Parker N, Westrick E. Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates. J Pharmacol Exp Ther. 2008;327:918-925. [PMID: 18791065 DOI: 10.1124/jpet.108.143206] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Tai W, Gao X. Ribonucleoprotein: A Biomimetic Platform for Targeted siRNA Delivery. Adv Funct Mater 2019;29:1902221. [DOI: 10.1002/adfm.201902221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Kim MH, Kim SG, Kim DW. A novel dual-modality imaging agent targeting folate receptor of tumor for molecular imaging and fluorescence-guided surgery. Ann Nucl Med 2019;33:606-16. [PMID: 31134434 DOI: 10.1007/s12149-019-01369-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Leamon CP, Vlahov IR, Reddy JA, Vetzel M, Santhapuram HK, You F, Bloomfield A, Dorton R, Nelson M, Kleindl P, Vaughn JF, Westrick E. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship. Bioconjug Chem 2014;25:560-8. [PMID: 24564229 DOI: 10.1021/bc400441s] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
4 Patel TK, Adhikari N, Amin SA, Biswas S, Jha T, Ghosh B. Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery. New J Chem 2021;45:5291-321. [DOI: 10.1039/d0nj04134c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
5 Huang J, Xue Y, Cai N, Zhang H, Wen K, Luo X, Long S, Yu F. Efficient reduction and pH co-triggered DOX-loaded magnetic nanogel carrier using disulfide crosslinking. Mater Sci Eng C Mater Biol Appl 2015;46:41-51. [PMID: 25491958 DOI: 10.1016/j.msec.2014.10.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
6 Patel NR, Piroyan A, Ganta S, Morse AB, Candiloro KM, Solon AL, Nack AH, Galati CA, Bora C, Maglaty MA, O'Brien SW, Litwin S, Davis B, Connolly DC, Coleman TP. In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers. Cancer Biol Ther 2018;19:554-64. [PMID: 29737910 DOI: 10.1080/15384047.2017.1395118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
7 Srinivasarao M, Low PS. Ligand-Targeted Drug Delivery. Chem Rev 2017;117:12133-64. [DOI: 10.1021/acs.chemrev.7b00013] [Cited by in Crossref: 218] [Cited by in F6Publishing: 186] [Article Influence: 43.6] [Reference Citation Analysis]
8 Voss KA, Riley RT, Gelineau-van Waes J. Fumonisin B 1 induced neural tube defects were not increased in LM/Bc mice fed folate-deficient diet. Mol Nutr Food Res 2014;58:1190-8. [DOI: 10.1002/mnfr.201300720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
9 Desale SS, Soni KS, Romanova S, Cohen SM, Bronich TK. Targeted delivery of platinum-taxane combination therapy in ovarian cancer. J Control Release 2015;220:651-9. [PMID: 26381902 DOI: 10.1016/j.jconrel.2015.09.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
10 Pöhner I, Quotadamo A, Panecka-Hofman J, Luciani R, Santucci M, Linciano P, Landi G, Di Pisa F, Dello Iacono L, Pozzi C, Mangani S, Gul S, Witt G, Ellinger B, Kuzikov M, Santarem N, Cordeiro-da-Silva A, Costi MP, Venturelli A, Wade RC. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1. J Med Chem 2022. [PMID: 35675511 DOI: 10.1021/acs.jmedchem.2c00232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tang YS, Khan RA, Xiao S, Hansen DK, Stabler SP, Kusumanchi P, Jayaram HN, Antony AC. Evidence Favoring a Positive Feedback Loop for Physiologic Auto Upregulation of hnRNP-E1 during Prolonged Folate Deficiency in Human Placental Cells. J Nutr 2017;147:482-98. [PMID: 28250194 DOI: 10.3945/jn.116.241364] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
12 Snyder AK, Rio RV. "Wigglesworthia morsitans" Folate (Vitamin B9) Biosynthesis Contributes to Tsetse Host Fitness. Appl Environ Microbiol 2015;81:5375-86. [PMID: 26025907 DOI: 10.1128/AEM.00553-15] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 4.9] [Reference Citation Analysis]
13 Voss KA, Riley RT, Gardner NM, Waes JG. Fumonisins. Reproductive and Developmental Toxicology. Elsevier; 2017. pp. 925-43. [DOI: 10.1016/b978-0-12-804239-7.00047-0] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Qi J, Tsuji K, Hymel D, Burke TR, Hudecek M, Rader C, Peng H. Chemically Programmable and Switchable CAR‐T Therapy. Angew Chem 2020;132:12276-83. [DOI: 10.1002/ange.202005432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Roti G, Qi J, Kitara S, Sanchez-Martin M, Saur Conway A, Varca AC, Su A, Wu L, Kung AL, Ferrando AA, Bradner JE, Stegmaier K. Leukemia-specific delivery of mutant NOTCH1 targeted therapy. J Exp Med 2018;215:197-216. [PMID: 29158376 DOI: 10.1084/jem.20151778] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
16 Singh D, McMillan J, Hilaire J, Gautam N, Palandri D, Alnouti Y, Gendelman HE, Edagwa B. Development and characterization of a long-acting nanoformulated abacavir prodrug. Nanomedicine (Lond) 2016;11:1913-27. [PMID: 27456759 DOI: 10.2217/nnm-2016-0164] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
17 Xiao S, Tang YS, Kusumanchi P, Stabler SP, Zhang Y, Antony AC. Folate Deficiency Facilitates Genomic Integration of Human Papillomavirus Type 16 DNA In Vivo in a Novel Mouse Model for Rapid Oncogenic Transformation of Human Keratinocytes. J Nutr 2018;148:389-400. [PMID: 29546304 DOI: 10.1093/jn/nxx060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kim MS, Ma JS, Yun H, Cao Y, Kim JY, Chi V, Wang D, Woods A, Sherwood L, Caballero D, Gonzalez J, Schultz PG, Young TS, Kim CH. Redirection of genetically engineered CAR-T cells using bifunctional small molecules. J Am Chem Soc 2015;137:2832-5. [PMID: 25692571 DOI: 10.1021/jacs.5b00106] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 12.1] [Reference Citation Analysis]
19 Kawakubo-Yasukochi T, Morioka M, Ohe K, Yasukochi A, Ozaki Y, Hazekawa M, Nishinakagawa T, Ono K, Nakamura S, Nakashima M. Maternal folic acid depletion during early pregnancy increases sensitivity to squamous tumor formation in the offspring in mice. J Dev Orig Health Dis 2019;10:683-91. [PMID: 31131784 DOI: 10.1017/S2040174419000217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Kim MH, Kim WH, Kim CG, Kim DW. Synthesis and Evaluation of (99m)Tc-Labeled Folate-Tripeptide Conjugate as a Folate Receptor-Targeted Imaging Agent in a Tumor-Bearing Mouse Model. Nucl Med Mol Imaging 2015;49:200-7. [PMID: 26279693 DOI: 10.1007/s13139-015-0336-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
21 Lee J, Termsarasab U, Park J, Lee SY, Ko S, Shim J, Chung S, Cho H, Kim D. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. Journal of Controlled Release 2016;236:38-46. [DOI: 10.1016/j.jconrel.2016.06.021] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
22 Kettenbach K, Reffert LM, Schieferstein H, Pektor S, Eckert R, Miederer M, Rösch F, Ross TL. Comparison Study of Two Differently Clicked 18F-Folates-Lipophilicity Plays a Key Role. Pharmaceuticals (Basel) 2018;11:E30. [PMID: 29562610 DOI: 10.3390/ph11010030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lu Y, Wollak KN, Cross VA, Westrick E, Wheeler LW, Stinnette TW, Vaughn JF, Hahn SJ, Xu LC, Vlahov IR, Leamon CP. Folate receptor-targeted aminopterin therapy is highly effective and specific in experimental models of autoimmune uveitis and autoimmune encephalomyelitis. Clin Immunol 2014;150:64-77. [PMID: 24333534 DOI: 10.1016/j.clim.2013.10.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
24 Péraudeau E, Cronier L, Monvoisin A, Poinot P, Mergault C, Guilhot F, Tranoy-opalinski I, Renoux B, Papot S, Clarhaut J. Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid. Journal of Controlled Release 2018;269:36-44. [DOI: 10.1016/j.jconrel.2017.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
25 Garcia GE, Lu YJ, Truong LD, Roncal-Jiménez CA, Miyazaki M, Miyazaki-Anzai S, Cara-Fuentes G, Andres-Hernando A, Lanaspa M, Johnson RJ, Leamon CP. A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats. Cells 2021;10:2113. [PMID: 34440885 DOI: 10.3390/cells10082113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Loureiro A, Bernardes GJ, Shimanovich U, Sárria MP, Nogueira E, Preto A, Gomes AC, Cavaco-Paulo A. Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors. Nanomedicine 2015;11:1077-83. [PMID: 25791804 DOI: 10.1016/j.nano.2015.02.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
27 Kelderhouse LE, Robins MT, Rosenbalm KE, Hoylman EK, Mahalingam S, Low PS. Prediction of Response to Therapy for Autoimmune/Inflammatory Diseases Using an Activated Macrophage-Targeted Radioimaging Agent. Mol Pharm 2015;12:3547-55. [PMID: 26333010 DOI: 10.1021/acs.molpharmaceut.5b00134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
28 Brooks HB, Meier TI, Geeganage S, Fales KR, Thrasher KJ, Konicek SA, Spencer CD, Thibodeaux S, Foreman RT, Hui YH, Roth KD, Qian YW, Wang T, Luo S, Torrado A, Si C, Toth JL, Mc Cowan JR, Frimpong K, Lee MR, Dally RD, Shepherd TA, Durham TB, Wang Y, Wu Z, Iversen PW, Njoroge FG. Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models. Sci Rep 2018;8:15458. [PMID: 30337562 DOI: 10.1038/s41598-018-33453-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Qi J, Tsuji K, Hymel D, Burke TR Jr, Hudecek M, Rader C, Peng H. Chemically Programmable and Switchable CAR-T Therapy. Angew Chem Int Ed Engl 2020;59:12178-85. [PMID: 32329959 DOI: 10.1002/anie.202005432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
30 Azaïs H, Moussaron A, Khodja Bach S, Bassil A, Betrouni N, Frochot C, Collinet P, Mordon S. FRα : une cible pour la thérapie photodynamique prophylactique des métastases péritonéales ovariennes ? Bulletin du Cancer 2014;101:1109-13. [DOI: 10.1684/bdc.2014.1977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Fales KR, Njoroge FG, Brooks HB, Thibodeaux S, Torrado A, Si C, Toth JL, Mc Cowan JR, Roth KD, Thrasher KJ, Frimpong K, Lee MR, Dally RD, Shepherd TA, Durham TB, Margolis BJ, Wu Z, Wang Y, Atwell S, Wang J, Hui YH, Meier TI, Konicek SA, Geeganage S. Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model. J Med Chem 2017;60:9599-616. [PMID: 29072452 DOI: 10.1021/acs.jmedchem.7b01046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
32 Varghese B, Paulos C, Low PS. Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis. Inflammation 2016;39:1345-53. [PMID: 27206918 DOI: 10.1007/s10753-016-0366-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
33 Jackman AL, Jansen G, Ng M. Folate Receptor Targeted Thymidylate Synthase Inhibitors. In: Jackman AL, Leamon CP, editors. Targeted Drug Strategies for Cancer and Inflammation. Boston: Springer US; 2011. pp. 93-117. [DOI: 10.1007/978-1-4419-8417-3_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Lee YG, Chu H, Lu Y, Leamon CP, Srinivasarao M, Putt KS, Low PS. Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters. Nat Commun 2019;10:2681. [PMID: 31213606 DOI: 10.1038/s41467-019-10565-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
35 Leamon CP, Reddy JA, Klein PJ, Vlahov IR, Dorton R, Bloomfield A, Nelson M, Westrick E, Parker N, Bruna K, Vetzel M, Gehrke M, Nicoson JS, Messmann RA, Lorusso PM, Sausville EA. Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications. J Pharmacol Exp Ther 2011;336:336-43. [DOI: 10.1124/jpet.110.175109] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
36 Poh S, Chelvam V, Low PS. Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomes. Nanomedicine (Lond) 2015;10:1439-49. [PMID: 25996118 DOI: 10.2217/nnm.14.237] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
37 Nukolova NV, Oberoi HS, Cohen SM, Kabanov AV, Bronich TK. Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 2011;32:5417-26. [PMID: 21536326 DOI: 10.1016/j.biomaterials.2011.04.006] [Cited by in Crossref: 166] [Cited by in F6Publishing: 153] [Article Influence: 15.1] [Reference Citation Analysis]
38 Rio RVM, Attardo GM, Weiss BL. Grandeur Alliances: Symbiont Metabolic Integration and Obligate Arthropod Hematophagy. Trends Parasitol 2016;32:739-49. [PMID: 27236581 DOI: 10.1016/j.pt.2016.05.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
39 Lu YJ, Chu H, Wheeler LW, Nelson M, Westrick E, Matthaei JF, Cardle II, Johnson A, Gustafson J, Parker N, Vetzel M, Xu LC, Wang EZ, Jensen MC, Klein PJ, Low PS, Leamon CP. Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies. Front Oncol 2019;9:151. [PMID: 30941303 DOI: 10.3389/fonc.2019.00151] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
40 Gautam N, Puligujja P, Balkundi S, Thakare R, Liu XM, Fox HS, McMillan J, Gendelman HE, Alnouti Y. Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations. Antimicrob Agents Chemother 2014;58:7510-9. [PMID: 25288084 DOI: 10.1128/AAC.04108-14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
41 Qi J, Hymel D, Nelson CG, Burke TR Jr, Rader C. Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1. Front Immunol 2019;10:1994. [PMID: 31497024 DOI: 10.3389/fimmu.2019.01994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
42 Sellmyer MA, Lee I, Hou C, Lieberman BP, Zeng C, Mankoff DA, Mach RH. Quantitative PET Reporter Gene Imaging with [11C]Trimethoprim. Mol Ther 2017;25:120-6. [PMID: 28129108 DOI: 10.1016/j.ymthe.2016.10.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
43 Hansen MF, Jensen SØ, Füchtbauer EM, Martensen PM. High folic acid diet enhances tumour growth in PyMT-induced breast cancer. Br J Cancer 2017;116:752-61. [PMID: 28152548 DOI: 10.1038/bjc.2017.11] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
44 Kopp M, Morisset R, Rychlik M. Characterization and Interrelations of One-Carbon Metabolites in Tissues, Erythrocytes, and Plasma in Mice with Dietary Induced Folate Deficiency. Nutrients 2017;9:E462. [PMID: 28475162 DOI: 10.3390/nu9050462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
45 Rana A, Bhatnagar S. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach. Bioorg Chem 2021;112:104946. [PMID: 33989916 DOI: 10.1016/j.bioorg.2021.104946] [Reference Citation Analysis]
46 Cora MC, Gwinn W, Wilson R, King D, Waidyanatha S, Kissling GE, Brar SS, Olivera D, Blystone C, Travlos G. A Black Cohosh Extract Causes Hematologic and Biochemical Changes Consistent with a Functional Cobalamin Deficiency in Female B6C3F1/N Mice. Toxicol Pathol 2017;45:614-23. [PMID: 28618975 DOI: 10.1177/0192623317714343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bonagas N, Gustafsson NMS, Henriksson M, Marttila P, Gustafsson R, Wiita E, Borhade S, Green AC, Vallin KSA, Sarno A, Svensson R, Göktürk C, Pham T, Jemth AS, Loseva O, Cookson V, Kiweler N, Sandberg L, Rasti A, Unterlass JE, Haraldsson M, Andersson Y, Scaletti ER, Bengtsson C, Paulin CBJ, Sanjiv K, Abdurakhmanov E, Pudelko L, Kunz B, Desroses M, Iliev P, Färnegårdh K, Krämer A, Garg N, Michel M, Häggblad S, Jarvius M, Kalderén C, Jensen AB, Almlöf I, Karsten S, Zhang SM, Häggblad M, Eriksson A, Liu J, Glinghammar B, Nekhotiaeva N, Klingegård F, Koolmeister T, Martens U, Llona-Minguez S, Moulson R, Nordström H, Parrow V, Dahllund L, Sjöberg B, Vargas IL, Vo DD, Wannberg J, Knapp S, Krokan HE, Arvidsson PI, Scobie M, Meiser J, Stenmark P, Berglund UW, Homan EJ, Helleday T. Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress. Nat Cancer 2022;3:156-72. [PMID: 35228749 DOI: 10.1038/s43018-022-00331-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
48 Christensen E, Henriksen JR, Jørgensen JT, Amitay Y, Shmeeda H, Gabizon AA, Kjær A, Andresen TL, Hansen AE. Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts. Int J Nanomedicine 2018;13:7647-56. [PMID: 30538449 DOI: 10.2147/IJN.S182579] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
49 Lu Y, Stinnette TW, Westrick E, Klein PJ, Gehrke MA, Cross VA, Vlahov IR, Low PS, Leamon CP. Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Arthritis Res Ther 2011;13:R56. [PMID: 21463515 DOI: 10.1186/ar3304] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
50 Anckaert E, Romero S, Adriaenssens T, Smitz J. Effects of Low Methyl Donor Levels in Culture Medium During Mouse Follicle Culture on Oocyte Imprinting Establishment1. Biology of Reproduction 2010;83:377-86. [DOI: 10.1095/biolreprod.109.082164] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
51 Leamon CP, Reddy JA, Vlahov IR, Dorton R, Bloomfield A, Vetzel M, Klein PJ, Westrick E, Xu L, Wang Y. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy. Cancer Chemother Pharmacol 2017;79:1151-60. [DOI: 10.1007/s00280-017-3311-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
52 Li YQ, Pan QJ, Liu ZH, Hu XH, Liao XL, Huang SQ. Efficacy of intraperitoneal versus intravenous pemetrexed administration in management of malignant ascites in mice bearing ascitic hepatoma-22. Shijie Huaren Xiaohua Zazhi 2012; 20(36): 3767-3772 [DOI: 10.11569/wcjd.v20.i36.3767] [Reference Citation Analysis]
53 Mckay JA, Mathers JC. Maternal folate deficiency and metabolic dysfunction in offspring. Proc Nutr Soc 2016;75:90-5. [DOI: 10.1017/s0029665115004280] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]